Logo image of BAM

BROOKFIELD ASSET MGMT-A (BAM) Stock Fundamental Analysis

USA - NYSE:BAM - CA1130041058 - Common Stock

54.2 USD
+0.04 (+0.07%)
Last: 10/17/2025, 8:04:00 PM
53.2287 USD
-0.97 (-1.79%)
After Hours: 10/17/2025, 8:04:00 PM
Fundamental Rating

5

Overall BAM gets a fundamental rating of 5 out of 10. We evaluated BAM against 237 industry peers in the Capital Markets industry. BAM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BAM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BAM had positive earnings in the past year.
In the past year BAM had a positive cash flow from operations.
In the past 5 years BAM has always been profitable.
Of the past 5 years BAM 4 years had a positive operating cash flow.
BAM Yearly Net Income VS EBIT VS OCF VS FCFBAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

Looking at the Return On Assets, with a value of 8.71%, BAM belongs to the top of the industry, outperforming 85.23% of the companies in the same industry.
BAM has a Return On Equity of 13.61%. This is in the better half of the industry: BAM outperforms 71.31% of its industry peers.
With a decent Return On Invested Capital value of 7.21%, BAM is doing good in the industry, outperforming 79.32% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BAM is significantly below the industry average of 7.58%.
The 3 year average ROIC (1.40%) for BAM is below the current ROIC(7.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.71%
ROE 13.61%
ROIC 7.21%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.4%
ROIC(5y)3.71%
BAM Yearly ROA, ROE, ROICBAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 57.13%, BAM belongs to the top of the industry, outperforming 94.94% of the companies in the same industry.
In the last couple of years the Profit Margin of BAM has grown nicely.
BAM has a better Operating Margin (51.12%) than 86.50% of its industry peers.
In the last couple of years the Operating Margin of BAM has declined.
Industry RankSector Rank
OM 51.12%
PM (TTM) 57.13%
GM N/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
BAM Yearly Profit, Operating, Gross MarginsBAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200 400 600 800 1K

7

2. Health

2.1 Basic Checks

BAM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BAM has been reduced compared to 5 years ago.
The debt/assets ratio for BAM has been reduced compared to a year ago.
BAM Yearly Shares OutstandingBAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BAM Yearly Total Debt VS Total AssetsBAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B

2.2 Solvency

BAM has an Altman-Z score of 9.58. This indicates that BAM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BAM (9.58) is better than 92.83% of its industry peers.
The Debt to FCF ratio of BAM is 2.32, which is a good value as it means it would take BAM, 2.32 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.32, BAM belongs to the top of the industry, outperforming 86.08% of the companies in the same industry.
A Debt/Equity ratio of 0.22 indicates that BAM is not too dependend on debt financing.
The Debt to Equity ratio of BAM (0.22) is better than 74.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 2.32
Altman-Z 9.58
ROIC/WACCN/A
WACCN/A
BAM Yearly LT Debt VS Equity VS FCFBAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B

2.3 Liquidity

A Current Ratio of 1.31 indicates that BAM should not have too much problems paying its short term obligations.
BAM has a Current ratio (1.31) which is comparable to the rest of the industry.
A Quick Ratio of 1.31 indicates that BAM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.31, BAM is in line with its industry, outperforming 59.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
BAM Yearly Current Assets VS Current LiabilitesBAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

BAM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.94%, which is quite good.
Measured over the past years, BAM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.95% on average per year.
The Revenue has grown by 531.03% in the past year. This is a very strong growth!
BAM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -26.01% yearly.
EPS 1Y (TTM)15.94%
EPS 3Y-15.34%
EPS 5Y-22.95%
EPS Q2Q%23.53%
Revenue 1Y (TTM)531.03%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-5.05%

3.2 Future

The Earnings Per Share is expected to grow by 15.67% on average over the next years. This is quite good.
BAM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.22% yearly.
EPS Next Y13.23%
EPS Next 2Y14.68%
EPS Next 3Y15.67%
EPS Next 5YN/A
Revenue Next Year11.73%
Revenue Next 2Y12.84%
Revenue Next 3Y13.22%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BAM Yearly Revenue VS EstimatesBAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
BAM Yearly EPS VS EstimatesBAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 33.88, BAM can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of BAM indicates a slightly more expensive valuation: BAM is more expensive than 75.53% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.40, BAM is valued a bit more expensive.
The Price/Forward Earnings ratio is 28.42, which means the current valuation is very expensive for BAM.
70.04% of the companies in the same industry are cheaper than BAM, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.94. BAM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 33.88
Fwd PE 28.42
BAM Price Earnings VS Forward Price EarningsBAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

BAM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 92.08
EV/EBITDA N/A
BAM Per share dataBAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BAM may justify a higher PE ratio.
BAM's earnings are expected to grow with 15.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.56
PEG (5Y)N/A
EPS Next 2Y14.68%
EPS Next 3Y15.67%

3

5. Dividend

5.1 Amount

BAM has a Yearly Dividend Yield of 2.12%.
Compared to an average industry Dividend Yield of 8.24, BAM is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.38, BAM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

BAM has paid a dividend for at least 10 years, which is a reliable track record.
As BAM did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years6
Div Non Decr Years6
BAM Yearly Dividends per shareBAM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BAM pays out 122.97% of its income as dividend. This is not a sustainable payout ratio.
DP122.97%
EPS Next 2Y14.68%
EPS Next 3Y15.67%
BAM Yearly Income VS Free CF VS DividendBAM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
BAM Dividend Payout.BAM Dividend Payout, showing the Payout Ratio.BAM Dividend Payout.PayoutRetained Earnings

BROOKFIELD ASSET MGMT-A

NYSE:BAM (10/17/2025, 8:04:00 PM)

After market: 53.2287 -0.97 (-1.79%)

54.2

+0.04 (+0.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-07 2025-11-07/bmo
Inst Owners17.36%
Inst Owner Change0%
Ins Owners1.9%
Ins Owner ChangeN/A
Market Cap88.77B
Analysts67.27
Price Target65.18 (20.26%)
Short Float %3.87%
Short Ratio7.67
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP122.97%
Div Incr Years6
Div Non Decr Years6
Ex-Date08-29 2025-08-29 (0.4375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.8%
Min EPS beat(2)-1.13%
Max EPS beat(2)6.73%
EPS beat(4)3
Avg EPS beat(4)3.2%
Min EPS beat(4)-1.13%
Max EPS beat(4)6.73%
EPS beat(8)5
Avg EPS beat(8)2.65%
EPS beat(12)8
Avg EPS beat(12)3.3%
EPS beat(16)10
Avg EPS beat(16)14.49%
Revenue beat(2)0
Avg Revenue beat(2)-16.78%
Min Revenue beat(2)-17.67%
Max Revenue beat(2)-15.9%
Revenue beat(4)0
Avg Revenue beat(4)-12.82%
Min Revenue beat(4)-17.67%
Max Revenue beat(4)-0.58%
Revenue beat(8)0
Avg Revenue beat(8)-9.19%
Revenue beat(12)1
Avg Revenue beat(12)-15.43%
Revenue beat(16)3
Avg Revenue beat(16)127.5%
PT rev (1m)-0.24%
PT rev (3m)10.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)0.57%
EPS NY rev (3m)-0.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 33.88
Fwd PE 28.42
P/S 36.07
P/FCF 92.08
P/OCF 91.89
P/B 8.59
P/tB 8.59
EV/EBITDA N/A
EPS(TTM)1.6
EY2.95%
EPS(NY)1.91
Fwd EY3.52%
FCF(TTM)0.59
FCFY1.09%
OCF(TTM)0.59
OCFY1.09%
SpS1.5
BVpS6.31
TBVpS6.31
PEG (NY)2.56
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.71%
ROE 13.61%
ROCE 9.83%
ROIC 7.21%
ROICexc 7.47%
ROICexgc 7.81%
OM 51.12%
PM (TTM) 57.13%
GM N/A
FCFM 39.17%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.4%
ROIC(5y)3.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.93%
ROCE(5y)4.85%
ROICexcg growth 3Y-36.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y-36.35%
ROICexc growth 5YN/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 2.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 21.69
Cash Conversion N/A
Profit Quality 68.56%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 9.58
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)18.12%
Cap/Sales(5y)11.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.94%
EPS 3Y-15.34%
EPS 5Y-22.95%
EPS Q2Q%23.53%
EPS Next Y13.23%
EPS Next 2Y14.68%
EPS Next 3Y15.67%
EPS Next 5YN/A
Revenue 1Y (TTM)531.03%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-5.05%
Revenue Next Year11.73%
Revenue Next 2Y12.84%
Revenue Next 3Y13.22%
Revenue Next 5YN/A
EBIT growth 1Y2319.23%
EBIT growth 3Y-62.73%
EBIT growth 5Y-39.83%
EBIT Next Year14.6%
EBIT Next 3Y17.48%
EBIT Next 5YN/A
FCF growth 1Y139.98%
FCF growth 3Y-25.34%
FCF growth 5Y-6.68%
OCF growth 1Y140.66%
OCF growth 3Y-24.26%
OCF growth 5Y-5.43%